跳至主要内容
临床试验/NCT07024511
NCT07024511尚未招募不适用

Effectiveness of Auricular Acupuncture for Migraine

Universiti Tunku Abdul Rahman2 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2025年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
156
试验地点
2
主要终点
headache frequency

研究概览

简要总结

Migraine is a primary headache disorder characterized by recurrent episodes of moderate to severe pain, frequently accompanied by nausea, photophobia, and phonophobia. It ranks as the third most prevalent medical condition globally and is recognized by the World Health Organization (WHO) as one of the top ten causes of disability worldwide. Migraine presents substantial public health concerns due to its considerable socioeconomic burden and its detrimental impact on individuals' quality of life. Although pharmacological treatments are widely available, their effectiveness is often limited, with many patients experiencing inadequate symptom relief or adverse side effects. Consequently, there has been growing interest in non-pharmacological approaches, particularly acupuncture and auricular therapy, due to their favorable safety profiles and reported efficacy in alleviating migraine symptoms. Auricular therapy, a microsystem of acupuncture applied to specific points on the external ear, has gained popularity for its simplicity, low risk, and therapeutic potential. Despite its increasing clinical use, robust scientific evidence supporting the effectiveness of auricular therapy for migraine remains insufficient, underscoring the need for well-designed clinical studies to validate its therapeutic value.

详细描述

Migraine is a complex and dynamic neurological disorder characterized by fluctuations in attack frequency, duration, severity, and associated symptoms, necessitating timely prevention and effective management strategies. While pharmacological treatments remain the mainstay, their limitations have led to increasing interest in non-pharmacological interventions such as acupuncture. Acupuncture has gained global recognition for its efficacy, particularly in migraine, which is one of the conditions most responsive to this therapy. Supported by strong clinical evidence, acupuncture is considered safe and well-tolerated, with a low incidence of adverse effects. Guidelines for managing primary headache disorders now advocate a range of complementary approaches, including acupuncture, dietary changes, physical activity, and cognitive behavioral therapy which reflecting a paradigm shift towards integrative care. Clinical studies have demonstrated that acupuncture can significantly reduce migraine frequency, shorten attack duration, and alleviate symptom severity. Mechanistic research suggests acupuncture modulates migraine pathophysiology through neuroimmune and neurotransmitter regulation, although further studies are needed to elucidate its molecular effects, particularly beyond the trigeminovascular system. Within Traditional Chinese Medicine, auricular therapy based on stimulating specific points on the external ear aligned with internal organ systems via the "inverted fetus" model offers a simplified, non-invasive modality that activates neural signaling pathways to regulate bodily functions and relieve migraine symptoms. Despite its growing clinical use, further clinical evidence is needed to confirm the therapeutic efficacy and mechanisms of auricular acupuncture in migraine management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed as having migraine with aura and without aura according to the diagnostic criteria specified by the ICHD 3;
  • Aged between 18 and 65 years old;
  • Provided written informed consent;
  • Headache lasting for 4 to 72 hours and occur at least 5 times (untreated or poorly treated);
  • At least 2 out of 4 criteria must be met (unilateral, pulsatile, moderate to severe pain, headache aggravated by daily physical activity, or avoidance of daily activities such as walking or climbing stairs due to headache);
  • At least one of the two criteria must be met (nausea and/or vomiting, photophobia, and fear of sound);
  • At least one fully recoverable premonitory symptom (visual, sensory, speech and/or language, motor, brainstem, retina); Onset time more than 5 minutes; (8) No prophylaxis treatments with acupuncture or drugs in the past 3 months; (9) Written informed consent provided.

排除标准

  • All other diagnoses of chronic, tension-type headache, cluster headache and/or secondary headaches;
  • History of psychotic disorder(s).;
  • Pregnancy or lactation;
  • Severe somatic disorder(s);
  • History of severe organic psychiatric disorder(s);
  • History of other chronic pain condition(s) in the pass 3 months;
  • History of addictive disorder(s);
  • Visual Aura Rating Scale, VARS≥5 score;
  • Taking long-term painkillers for more than 1 month within 3 months.

结局指标

主要结局

headache frequency

时间窗: from baseline to 1 month post treatment.

The frequency of headaches will be recorded in the form of a headache diary, and doctors will conduct electronic inquiries in WeChat groups every day.

次要结局

  • pain severity(from baseline to 1 month post treatment.)
  • migraine disability(from baseline to 1 month post treatment)
  • Change of baseline in the mean quality of life as assessed by Migraine-Specific Quality of Life Questionnaire at 1 month(from baseline to 1 month post treatment)
  • physical (physical function, pain intensity), mental (depression, anxiety, fatigue, sleep disturbance) and social (ability to participate in social roles and activities).(from baseline to 1 month post treatment)
  • treatment success(at immediate post treatment)
  • red blood cell distribution width (RDW)(from baseline to immediate post treatment)
  • adverse side effects(up to 48 hours after each treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Foo Chai Nien

Associate Professor

Universiti Tunku Abdul Rahman

研究点 (2)

Loading locations...

相似试验